Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis Efficacy and Safety of AbGn-168Hin Patients With Moderate to Severe Active, Anti-TNF Alpha and/or An ...
Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial Efficacy and Safety of AbGn-168Hin Patients With Moderate to Severe Active, Anti-TNF Alpha and/or An ...